OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Publication Date
Release Date
2024
(6)
2021
(6)
2025
(5)
2022
(3)
2019
(2)
2018
(2)
2023
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Not available
S-EPMC7095489
|
biostudies-literature
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
Not available
S-EPMC11217869
|
biostudies-literature
Cite
Novel risk loci for COVID-19 hospitalization among admixed American populations.
Not available
S-EPMC11449485
|
biostudies-literature
Cite
Risk factors for eczema in infants born in Cuba: a population-based cross-sectional study.
Not available
S-EPMC3987161
|
biostudies-literature
Cite
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Not available
S-EPMC11335038
|
biostudies-literature
Cite
Novel genes and sex differences in COVID-19 severity.
Not available
S-EPMC9652109
|
biostudies-literature
Cite
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327
|
biostudies-literature
Cite
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Not available
S-EPMC6888890
|
biostudies-literature
Cite
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Not available
S-EPMC6889917
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets